Intravenous Immunoglobulin and Dermatomyositis-Associated Venous Thromboembolism

被引：6
作者：
Rotrosen, Elizabeth T. [1 ,2 ]
Niaki, Omid Zahedi [2 ,3 ]
Kassamali, Bina [2 ,3 ]
Lonowski, Sarah [2 ,3 ]
Shahriari, Neda [2 ,3 ]
LaChance, Avery [2 ,3 ]
Vleugels, Ruth Ann [2 ,3 ]
机构：
[1] Boston Univ, Sch Med, Boston, MA USA
[2] Brigham & Womens Hosp, Dept Dermatol, 221 Longwood Ave, Boston, MA 02115 USA
[3] Harvard Med Sch, Boston, MA USA
来源：
JAMA DERMATOLOGY | 2023年 / 159卷 / 06期
关键词：
POLYMYOSITIS; RISK;
D O I：
10.1001/jamadermatol.2023.1105
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
This cohort study investigated the association between treatment of dermatomyositis with intravenous immunoglobulin and thromboembolic events.
引用
收藏
页码：666 / 667
页数：2
相关论文
共 50 条
[21]   miR-1 is a novel biomarker for polymyositis/dermatomyositis-associated interstitial lung disease [J].
Sugiyama, Yumiko ;
Yoshimi, Ryusuke ;
Takeno, Mitsuhiro ;
Kunishita, Yosuke ;
Kishimoto, Daiga ;
Kamiyama, Reikou ;
Kirino, Yohei ;
Ohno, Shigeru ;
Nakajima, Hideaki .
MODERN RHEUMATOLOGY, 2020, 30 (05) :878-883
[22]   Cost-Utility Analysis of Intravenous Immunoglobulin for the Treatment of Steroid-Refractory Dermatomyositis in Thailand [J].
Bamrungsawad, Naruemon ;
Chaiyakunapruk, Nathorn ;
Upakdee, Nilawan ;
Pratoomsoot, Chayanin ;
Sruamsiri, Rosarin ;
Dilokthornsakul, Piyameth .
PHARMACOECONOMICS, 2015, 33 (05) :521-531
[23]   The therapeutic efficacy and safety of intravenous immunoglobulin in dermatomyositis and polymyositis: A systematic review and meta-analysis [J].
Xiong, Anji ;
Qiang, Yiying ;
Cao, Yuzi ;
Shuai, Yu ;
Chen, Huini ;
Xiang, Qilang ;
Hu, Ziyi ;
Song, Zhuoyao ;
Zhou, Shifeng ;
Zhang, Yan ;
Cui, Hongxu ;
Wang, Ye ;
Luo, Jie ;
Shuai, Shiquan ;
Yang, Yuan .
MODERN RHEUMATOLOGY, 2023, 33 (03) :533-542
[24]   Travel-Associated Venous Thromboembolism [J].
Johnson, Isla McKerrow ;
Shatzel, Joseph ;
Olson, Sven ;
Kohl, Tovah ;
Hamilton, Andrew ;
DeLoughery, Thomas G. .
WILDERNESS & ENVIRONMENTAL MEDICINE, 2022, 33 (02) :169-178
[25]   Pretreatment mortality risk prediction model in patients with polymyositis/dermatomyositis-associated interstitial lung disease [J].
Gui, Xianhua ;
Li, Wangzhong ;
Jiang, Hanyi ;
Wang, Rujia ;
Yu, Min ;
Zhao, Tingting ;
Ma, Miao ;
Ding, Jingjing ;
Jin, Ziyi ;
Qiu, Yuying ;
Qiu, Xiaohua ;
Zhang, Yingwei ;
Cao, Min ;
Huang, Mei ;
Cao, Mengshu ;
Dai, Jinghong ;
Cai, Hourong ;
Xin, Xiaoyan ;
Xiao, Yonglong .
RMD OPEN, 2024, 10 (02)
[26]   Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease [J].
Hozumi, Hironao ;
Fujisawa, Tomoyuki ;
Nakashima, Ran ;
Johkoh, Takeshi ;
Sumikawa, Hiromitsu ;
Murakami, Akihiro ;
Enomoto, Noriyuki ;
Inui, Naoki ;
Nakamura, Yutaro ;
Hosono, Yuji ;
Imura, Yoshitaka ;
Mimori, Tsuneyo ;
Suda, Takafumi .
RESPIRATORY MEDICINE, 2016, 121 :91-99
[27]   Increased Risk of Venous Thromboembolism in Patients with Dermatomyositis/Polymyositis: A Nationwide Cohort Study [J].
Chung, Wei-Sheng ;
Lin, Cheng-Li ;
Sung, Fung-Chang ;
Lu, Chuan-Chin ;
Kao, Chia-Hung .
THROMBOSIS RESEARCH, 2014, 134 (03) :622-626
[28]   Successful treatment for conventional treatment-resistant dermatomyositis-associated interstitial lung disease with adalimumab [J].
Park, Jin-Kyoung ;
Yoo, Han-Gyul ;
Ahn, Dae-Seon ;
Jeon, Hyun-Soon ;
Yoo, Wan-Hee .
RHEUMATOLOGY INTERNATIONAL, 2012, 32 (11) :3587-3590
[29]   Transcriptome Sequencing Identifies PLAUR as an Important Player in Patients With Dermatomyositis-Associated Interstitial Lung Disease [J].
Chen, Juan ;
Zhang, Ruixian ;
Xie, Min ;
Luan, Chunyan ;
Li, Xiaolan .
FRONTIERS IN GENETICS, 2021, 12
[30]   Intravenous immunoglobulin and risk of incident arterial or venous thromboembolism in 502,536 individuals: Evidence from the UK Biobank cohort [J].
Kapoor, Mahima ;
Bonnett, Laura ;
Lunn, M. ;
Carr, Aisling ;
Reilly, Mary .
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2020, 25 (04) :514-514
12345